Cancer Vaccine Stops Melanoma Return in 1,100 Patients

A personalized mRNA cancer vaccine just achieved its first major trial success, stopping melanoma from returning in patients who had tumors removed.

The breakthrough could launch an entirely new way to fight cancer by 2027.